Home/ Stocks/ TVGN

Tevogen Bio Holdings Inc. Common Stock

TVGN XNAS

$5.22 -0.46 (-8.29%) ▼ 15-min delayed

Open

$5.51

High

$5.51

Low

$5.07

Volume

23.5K

Market Cap

$22.47M

About Tevogen Bio Holdings Inc. Common Stock

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 17 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$-62,340	$-5,726,812	$-0.03
Q2 2025	$-38,033	$-5,503,979	$-0.03
Q1 2025	$0	$-10,367,061	$-0.07
FY 2024	$0	$-13,727,380	$-0.07

Earnings & Analyst Ratings

Next Earnings: Tue, May 12, 2026

Calendar →

Related Market News

No specific coverage for TVGN yet. Check out our latest market news or earnings calendar.

Get TVGN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Tevogen Bio Holdings Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.